The Canadian Public Lab That Could Have Helped Fight COVID-19 Pandemic
The coronavirus outbreak may finally help expose the fallacy of the notion that the private marketplace is innately superior. By Linda McQuaig Toronto Star (3/11/20) Canada once had a publicly owned pharmaceutical company that could have made a difference in the current coronavirus crisis — except that we sold it. Connaught Labs was a superstar in global medicine. For seven decades, this publicly owned Canadian company performed brilliantly on the national and international stage, contributing to medical breakthroughs and developing affordable treatments and vaccines for deadly diseases. Hated by its corporate competitors, Connaught was unique among pharmaceutical companies in that its focus was on human…